Search research articles
Contact Us
Filters
Showing results (11-20 of 103) with videos related to
Page
of 11
Sort By:
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Impaired brain glucose metabolism in patients with Down syndrome
O Labudova, N Cairns, E Kitzmüller, et al.
Psychological Medicine
|
August 1, 1993
Neuropathological basis for drawing disability (constructional apraxia) in Alzheimer's disease
H Förstl, A Burns, R Levy, et al.
Postgraduate Medical Journal
|
August 1, 1991
Medical disorders in Alzheimer's disease and vascular dementia
H Förstl, N Cairns, A Burns, et al.
Electrophoresis
|
May 27, 1999
Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease
S Greber, G Lubec, N Cairns, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 1, 1994
Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease
H Förstl, A Burns, R Levy, et al.
Electrophoresis
|
November 5, 1999
Enrichment of human brain proteins by heparin chromatography
K Karlsson, N Cairns, G Lubec, et al.
Neuroscience Letters
|
February 20, 1999
Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome
G Lubec, O Labudova, N Cairns, et al.
Neurobiology of Aging
|
July 11, 2001
Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease
R Vlkolinský, N Cairns, M Fountoulakis, et al.
Neuroscience Letters
|
August 22, 1997
Evidence against increased glycoxidation in patients with Alzheimer's disease
R Seidl, E Schuller, N Cairns, et al.
Neuroscience Letters
|
February 15, 2001
Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease
S H Kim, N Cairns, M Fountoulakisc, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 103) with videos related to
Sort By:
Page
of 11
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Impaired brain glucose metabolism in patients with Down syndrome
O Labudova, N Cairns, E Kitzmüller, et al.
Psychological Medicine
|
August 1, 1993
Neuropathological basis for drawing disability (constructional apraxia) in Alzheimer's disease
H Förstl, A Burns, R Levy, et al.
Postgraduate Medical Journal
|
August 1, 1991
Medical disorders in Alzheimer's disease and vascular dementia
H Förstl, N Cairns, A Burns, et al.
Electrophoresis
|
May 27, 1999
Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease
S Greber, G Lubec, N Cairns, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 1, 1994
Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease
H Förstl, A Burns, R Levy, et al.
Electrophoresis
|
November 5, 1999
Enrichment of human brain proteins by heparin chromatography
K Karlsson, N Cairns, G Lubec, et al.
Neuroscience Letters
|
February 20, 1999
Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome
G Lubec, O Labudova, N Cairns, et al.
Neurobiology of Aging
|
July 11, 2001
Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease
R Vlkolinský, N Cairns, M Fountoulakis, et al.
Neuroscience Letters
|
August 22, 1997
Evidence against increased glycoxidation in patients with Alzheimer's disease
R Seidl, E Schuller, N Cairns, et al.
Neuroscience Letters
|
February 15, 2001
Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease
S H Kim, N Cairns, M Fountoulakisc, et al.
Page
of 11